Lipella Pharmaceuticals Inc.
LIPO- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347242
No open-market purchases or sales by Lipella Pharmaceuticals Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Lipella Pharmaceuticals Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 3 | 0 | −3 |
| Shares | 2.84K | 0 | −2.84K (−100.0%) |
| Value | $7.13K | $0 | −$7.13K (−100.0%) |
New holders (0)
Institutions that held Lipella Pharmaceuticals Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (3)
Institutions that held Lipella Pharmaceuticals Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 2,708 | $6.80K |
| MAI Capital Management | 125 | $314 |
| Bank of America Corp | 7 | $18 |